YD Bio Ltd
YDES
8 hedge funds and large institutions have $1.23M invested in YD Bio Ltd in 2026 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 5 increasing their positions, 1 reducing their positions, and 2 closing their positions.
400% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 1
0.03% more ownership
Funds ownership: 0.2% → 0.23% (+0.03%)
20% less funds holding
Funds holding: 10 → 8 (-2)
29% less capital invested
Capital invested by funds: $1.73M → $1.23M (-$498K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$76.3K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$42.8K |
| 3 |
CCMW
Cypress Capital Management (Wyoming)
Sheridan,
Wyoming
|
+$30.4K |
| 4 |
WAM
Wolverine Asset Management
Chicago,
Illinois
|
+$22.9K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$18.1K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citigroup
New York
|
-$20.8K |
| 2 |
Morgan Stanley
New York
|
-$734 |
| 3 |
Bank of America
Charlotte,
North Carolina
|
-$61 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Geode Capital Management
Boston,
Massachusetts
| $464K | +$18.1K | +1,873 | +3% |
|
2
Cerity Partners
New York
| $250K | – | – | – |
|
|
CCMW
3
Cypress Capital Management (Wyoming)
Sheridan,
Wyoming
| $236K | +$30.4K | +3,150 | +11% |
|
|
4
Citadel Advisors
Miami,
Florida
| $150K | +$76.3K | +7,901 | +68% |
|
|
5
UBS Group
Zurich,
Switzerland
| $89.5K | +$42.8K | +4,436 | +62% |
|
|
WAM
6
Wolverine Asset Management
Chicago,
Illinois
| $37.6K | +$22.9K | +2,370 | +94% |
|
|
7
Morgan Stanley
New York
| $1.72K | -$734 | -76 | -25% |
|
8
Fidelity Investments
Boston,
Massachusetts
| $8 | – | – | – |
|
|
9
Citigroup
New York
| – | -$20.8K | -1,709 | Closed |
|
|
10
Bank of America
Charlotte,
North Carolina
| – | -$61 | -5 | Closed |
|
YDES Hedge Fund Activity: Q1 2026 in Review
8 of the 8,128 institutional investors tracked by Wall St. Rank reported a position in YD Bio Ltd (YDES) for Q1 2026, worth a combined $1.23M — down 29% from $1.73M a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of YDES and 0 opened new positions — a net loss of 2 holders — while 1 trimmed existing stakes and 5 added.
The largest buyer was Citadel Advisors, adding an estimated $76.3K. The largest seller was Citigroup, exiting entirely with an estimated $20.8K sold.
- 8 institutional investors held YD Bio Ltd (YDES) as of Q1 2026, down from 10 in Q4 2025.
- Funds reported $1.23M of YD Bio Ltd stock for Q1 2026, down 29% quarter-over-quarter.
- 0 funds opened new YD Bio Ltd positions in Q1 2026 and 2 closed out, a net change of -2 holders.
- The largest YD Bio Ltd buyer in Q1 2026 was Citadel Advisors, an estimated $76.3K added.
- The largest YD Bio Ltd seller in Q1 2026 was Citigroup, an estimated $20.8K sold.
Based on aggregated 13F filings for Q1 2026.